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Low FCGR3 copy numbers (CNs) has been associated with susceptibility to several
systemic autoimmune diseases. However, inconsistent associations were reported and
errors caused by shaky methods were suggested to be the major causes. In large
scale case control association studies, robust copy number determination method is
thus warranted, which was the main focus of the current study. In the present study,
FCGR3 CNs of 90 HapMap Asians were firstly checked using four assays including
paralog ratio test combined with restriction enzyme digest variant ratio (PRT-REDVR),
real-time quantitative (qPCR) using TaqMan assay, real-time qPCR using SYBR Green
dye and short tenden repeat (STR). To improve the comparison precision reproductively,
the results were compared with those from recently released sequencing data from
1000 genomes project as well as whole-genome tiling BAC array data. The tendencies
of inconsistent samples by these methods were also characterized. Refined in-home
TaqMan qPCR assay showed the highest correlation with array-CGH results (r = 0.726,
p < 0.001) and the highest concordant rate with 1000 genome sequencing data
(FCGR3A 91.76%, FCGR3B 85.88%, and FCGR3 81.18%). For samples with copy
number variations, comprehensive analysis of multiple methods was required in order
to improve detection accuracy. All these method were prone to detect copy number to
be higher than that from direct sequencing. All the four PCR based CN determination
methods (qPCR using TaqMan probes or SYBR Green, PRT, STR) were prone to higher
estimation errors and thus may lead to artificial associations in large-scale case-control
association studies. But different to previous reports, we observed that properly refined
TaqMan qPCR assay was not inferior to or even more accurate than PRT when using
sequencing data as the reference.
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INTRODUCTION
Fcγ receptors were cellular receptors, which were encoded
by FCGR3 locus, for the Fc region of IgG and IgE, and
could transmit their signal by tyrosine-based activation (ITAM)
or inhibitory motifs (ITIM). Low-affinity activating receptor
FcγRIII genes, which encoded FcγRIIIA and FcγRIIIB, were
located in 1q23.3 with extensive copy number variation (CNV)
(Redon et al., 2006; Nimmerjahn and Ravetch, 2008). Low copy
number of FCGR3B had been identified to be associated with
a number of systemic autoimmune diseases, such as systemic
lupus erythematosus (SLE), rheumatoid arthritis (RA), ANCA-
associated vasculitis (AAV), and anti-glomerular basement (anti-
GBM disease) disease (Fanciulli et al., 2007; Willcocks et al.,
2008; Mamtani et al., 2010; McKinney et al., 2010; Niederer
et al., 2010; Zhou et al., 2010, 2011; Molokhia et al., 2011; Chen
et al., 2014). However, results for disease associations were not
consistent, even for the same phenotype in populations within
the same ancestry. Phenotype and genetic heterogeneity might
be confounding factors. However, methodology discrepancies
were suggested to be the major factor leading to the conflicting
results. Certain proportion of errors might lead to false
associations, especially when the effect of gene risk was moderate.
Thus, in large-scale genetic association studies, easy, economic,
robust, and accurate methods of FCGR CN genotyping were
prerequisites.
Up to date, multiple assays for FCGR CN genotyping had
been developed, including real-time quantitative PCR (qPCR),
paralog ratio test combined with restriction enzyme digest
variant ratio (PRT-REDVR), multiples ligation-dependent probe
amplification (MLPA), short tenden repeat (STR), comparative
genomic hybridization (CGH), and direct sequencing (Aitman
et al., 2006; Fanciulli et al., 2007; Breunis et al., 2008, 2009;
Willcocks et al., 2008; Mamtani et al., 2010). But due to high
similarity and CN complexity in the region, no single method
or single test was suggested to be ideal in fastness, accuracy and
economy. Though sequencing data was the gold standard, it was
not suitable for large scale case-control study considering the
expenses. Our aim was to evaluate the efficacy of the widely
used methods and find a robust assay with a low error rate for
further large-scale case control genetic association study. In the
current study, we determined the copy numbers for 90 HapMap
Chinese Han from Beijing (CHB) and Japanese from Tokyo
(JPT) individuals using four copy number assays: PRT-REDVR,
TaqMan qPCR, SYBR Green qPCR, and STR (Fanciulli et al.,
2007; Hollox et al., 2009; Zhou et al., 2010), as thesemethods were
more widely taken and economical for large-scale association.
We compared our results of each method with the copy numbers
from established open database including the whole-genome
tiling BAC array data and the 1000 genome sequencing data.
Notably, thanks to the 1000 Genomes Project phase 3,
an integrated map of structural variation in 2504 human
genomes which was constructed in 2015. It presented the
most comprehensive set of human structural variants to date.
As an integrated resource for disease and population genetic
studies, it represented an invaluable resource for the construction
and analysis of personalized genomes. In terms of method
comparison, it was also of special importance, as it revealed
CN variations at individual instead of pooling level (Sudmant
et al., 2015). Thus, to improve the comparison efficiency, the
sequencing data from 1000G samples represented as the gold
standard available compared to previous reports replying on
CGH data. In this way, we were aiming to find a method
in FCGR3 copy number detection which was the fastest and
cheapest without scarifying accuracy.
MATERIALS AND METHODS
Subjects
The study population was based on the HapMap Phase II
Han Chinese individuals from Beijing (CHB, n = 45) and
Japanese individuals from Tokyo (JPT, n = 45). Genomic DNA
was purchased from the Coriell Cell Repositories (Catalog ID:
HAPMAPPT02). This study was approved by the Medical Ethics
Committee of Peking University First Hospital.
Real-Time Quantitative PCR (qPCR)
TaqMan qPCR System
FCGR3B and FCGR3B copy number (CN), determined by
Quantitative PCR (qPCR), was performed on an Applied
Biosystems 7500 (Foster City, CA, USA) as previously reported
(Zhou et al., 2010). Primers and TaqMan probes specifically
amplify the target gene were designed to avoid paralogous or
allelic sequence variants. Coagulation factor V gene (F5) was
included as an internal control for copy number. The qPCRs was
in 50 ul reaction system including 80 ng genomic DNA, 5ul 10
× PCR buffer, 4 ul 2.5mM deoxyribonucleoside triphosphate,
15 pmol/each forward primers, 15 pmol/each reverse primers,
5 pmol/each TaqMan probes, 1.5 U Taq polymerase (Takara,
Dalian, China), and 26.7ul ddH2O. Cycling conditions were 94
◦C
for 10min, 40 cycles with 10 s denaturation step at 94◦C, followed
by 62◦C (FCGR3B or FCGR3B) annealing step for 45 s and a 72◦C
extension step for 10 s (Zhou et al., 2010). The target gene and
the control gene were amplified in the same tube and each test
was run in triplicate. The standard curves to test the efficiency of
the assay were run using independent genomic DNA (Zhou et al.,
2010).
SYBR Green qPCR System
FCGR3B copy number assay was also carried out by SYBR Green
qPCR system, performed on an Applied Biosystems 7500 (Foster
City, CA, USA) and analyzed by the relative standard curve
method. The primers, qPCR reactions, and calculation were
referred to previous reports (Aitman et al., 2006).
Paralog Ratio Test (PRT)
The primer pair FCGR3A/FCGR3B co-amplified in FCGR3A
and FCGR3B. The other primer pair, FCGR3/c18, amplified
a sequence of the same length in both target genes and a
third region in Chromosome 18 (Niederer et al., 2010). The
amplification of 5–10 ng of genomic DNA in PCR reaction was
performed using Phusion Hot Start High Fidelity polymerase
(Finnzymes) with the HF buffer. The cycling conditions were
98◦C for 60 s, then 30 cycles at 98◦C for 10 s, annealing at
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65◦C (for FCGR3A/FCGR3B) or 60◦C (for FCGR3/c18) for
20 s and elongation at 72◦C for 30 s (for FCGR3A/FCGR3B)
or 5 s (for FCGR3/c18), followed by 72◦C for 7min to reduce
single stranded DNA products (Niederer et al., 2010). The
PCR products were added to Hi-DiTM Formamide with the
fluorescent GeneScanTM 500 LIZTM Size Standard (Applied
Biosystems) and the following analysis were performed on ABI
3730 × l DNA Analyzer/Sequencer (Applied Biosystems). Peak
areas corresponding to the two products were recorded for
HEX-labeled products using GeneMapper 4.0 software (Applied
Biosystems).
Restriction Enzyme Digest Variant Ratio
(REDVR)
In the present study, we performed two REDVR assays in order
to distinguish the variants from FCGR3B and FCGR3B (C733
Arginine > Stop) and to distinguish human neutrophil antigens
(HNA) HNA1a and HNA1b on FCGR3B (C147T). The primer
sequences were referred to previously published article (Hollox
et al., 2009). We amplified the two regions in duplex using
the same conditions as the PRT described above with some
modification. Copy number calls were estimated based on mean
ratios of the product and the reference standard for experimental
calibration. Amaximum likelihood approach was used to analyze
the PRT copy number calls in combination with the REDVR
analysis.
Short Tandem Repeat (STR)
The primers for STR could be referred to previously report
(Hollox et al., 2009). The PCR condition was based on PRT with
some modifications, that was, 26 cycles for amplification and
2µl for capillary electrophoresis analysis. During amplification,
the wrong replication of Taq DNA polymerase would generate
slippage peaks in MSAT1 amplification. The 2 bp larger real
peak would add to the area under the slippage peak in case that
the two peaks failed to overlap. It was difficult to distinguish a
slippage peak from a real peak which were 2 bp. Given that the
amount of slippage peak was dependent on the proportional to
variant length, we corrected a length dependent factor to real
peaks which coinciding with slippage peaks. If it showed more
than two peaks, the peak which had the second smallest area was
used to divide the area of each peak. If it showed more than four
peaks, the peak with the third smallest area was used to divide the
area of each peak. In this way, we determined the value for copy
numbers after slippage correction.
RESULTS
Respective Comparisons among All the 4
PCR Based CN Determination Assays
In the present study, we performed 4 methods with 3 repeats
(TaqMan qPCR, PRT-REDVR, SYBR Green qPCR, and STR) to
estimate the copy numbers for FCGR3 locus in CHB (n = 45)
and JPT (n = 45) populations (detailed copy number results for
FCGR3A, FCGR3B, and FCGR3 by each method was shown in
Table S1).
We next analyzed the concordant rate for FCGR3A, FCGR3B,
and FCGR3 with two or three assays (TaqMan qPCR, PRT,
REDVR, SYBR Green qPCR).
In two assay concordant analysis, TaqMan qPCR showed the
highest concordant rate with other methods. The concordant
rates were 77.78 ∼ 91.11% (91.11% for FCGR3A, 84.44% for
FCGR3B, and 77.78% for FCGR3) between TaqMan qPCR
and PRT-REDVR, 74.44% for FCGR3B between TaqMan
qPCR and SYBR Green, and 76.67% for FCGR3 between TaqMan
qPCR and STR. SYBR Green (74.44% with TaqMan qPCR
and 65.56% with PRT-REDVR for FCGR3B) and STR (76.67%
with TaqMan qPCR and 61.11% with PRT-REDVR for FCGR3)
showed the lowest concordant rate with other methods. In three
assay analysis, the concordant rates were much poorer, 62.22%
for FCGR3B (TaqMan qPCR, PRT-REDVR and SYBRGreen) and
60.00% for FCGR3 (TaqMan qPCR, PRT-REDVR and STR). This
result was consistent with previous observations (Haridan et al.,
2015).
Not only TaqMan and SYBR Green were qPCR based
methods, PRT, REDVR, and STR were also partly qPCR based
in methodology. They might skew toward same mistakes in copy
number detection. In general, even if these methods showed good
concordant rate with each other, it was hard to determine which
one was the most suitable method in FCGR3A, FCGR3B, and
FCGR3 copy number detection. In order to solve the problem, all
the results by these methods (TaqMan qPCR, PRT-REDVR, and
STR) should be tested with a “gold standard” in paired samples.
Correlation with the Whole-Genome Tiling
BAC Array Data
Weusedwhole-genome tiling BAC array data from theWellcome
Trust Sanger Institute in paired samples as reference, which was
more widely used in previous method reports (Redon et al.,
2006). As shown in Figure 1, all of TaqMan qPCR, PRT and STR
results showed a significant correlation with array-CGH results
(p < 0.001). Amongst, TaqMan qPCR assay showed the highest
correlation with array-CGH results with r = 0.726 (p < 0.001).
There was also a significant correlation between PRT (r= 0.667, p
< 0.001), STR (r = 0.677, p < 0.001) with the array-CGH results
(Figure 1). It also indicated that all the four methods had good
performance for CN calculation in tendency.
Correlation with the 1000 Genome
Sequencing Data
However, copy numbers were integers instead of linear ones. We
conducted a concordant analysis between our TaqMan qPCR,
PRT, REDVR, STR, SYBR Green qPCR results of FCGR3A,
FCGR3B, FCGR3 and the sequencing data from the 1000 genome
phase-3-structural-variant-dataset in paired samples (Sudmant
et al., 2015) (Figure 2). A significantly increased inconsistency
was observed for every method.
For single method precision, TaqMan qPCR assay still showed
the highest concordant rate with the sequencing results for
FCGR3A (91.76%), FCGR3B (85.88%), and FCGR3 (81.18%).
PRT-REDVER showed the lowest concordant rate for FCGR3
(72.94%). The concordant rate was also low in SYBRGreen qPCR
assay for FCGR3B (75.29%) and STR assay for FCGR3 (75.29%).
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FIGURE 1 | Correlation analysis of copy number measurements with array-CGH. TaqMan qPCR (A, r = 0.726), PRT-REDVR (B, r = 0.667) and STR (C, r =
0.677) were significant correlated with array-CGH results (p < 0.001).
FIGURE 2 | Concordant analysis of CNV measurement with 1000 genome sequencing data. Concordant rate between 1000 genome sequencing data and
PRT-REDVR of FCGR3A (A), 1000 genome sequencing data and TaqMan qPCR of FCGR3A (B), 1000 genome sequencing data and PRT-REDVR of FCGR3B (C),
1000 genome sequencing data and SYBR qPCR of FCGR3B (D), 1000 genome sequencing data and TaqMan qPCR of FCGR3B (E), 1000 genome sequencing data
and PRT of FCGR3 (F), 1000 genome sequencing data and STR of FCGR3 (G), 1000 genome sequencing data and TaqMan qPCR of FCGR3 (H).
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FIGURE 3 | Characteristics of wrong detected copy numbers. The percentage (%) of wrong detected copy number by every measurement for each copy of
FCGR3A (A), FCGR3B (B), and FCGR3 (C) was labeled above the column. If the copy number were detected higher than the sequencing data, the column would be
colored red. If the copy number were detected lower than the sequencing data, the column would be colored green.
Error was observed in almost every copy number detection
assay (Figure 2). Although there was 0–5% error rate for wrong
classification of varied copy numbers, it was strange that the
highest error rate was observed in FCGR3A and FCGR3B 2-copy
(8.24–20.00% error rate) and FCGR3 4-copy (14.12–17.65%). For
2-copy detection, TaqMan showed the lowest error rate 8.24%
for FCGR3A, 11.76% for FCGR3B, and 14.12% for FCGR3. PRT
showed a higher error rate in 2-copy detection, 12.94% for
FCGR3A, 16.47% for FCGR3B, and 17.65% for FCGR3. The SYBR
Green showed the highest error rate with 20.00% in FCGR3B
2-copy detection. This observation suggested that erroneous
copy number determination might be increased due to wrong
counting of the diploid nature of the genome.
And in all methods, the wrong detections tended to be higher
estimation (Figure 3). 2-copy for FCGR3A, 1-copy and 2-copy
for FCGR3B, and 3-copy, 4-copy, and 5-copy for FCGR3 were
skewing toward higher estimated in all the utilized methods.
FCGR3A showed that wrong detected samples by TaqMan qPCR
and PRT-REDVR were all estimated to be higher. For FCGR3B
and FCGR3 wrong detected samples, both higher and lower
estimations were observed in TaqMan qPCR, PRT, REDVR, and
STR, in which higher estimation took up the majority. 100%
SYBR Green wrong detected samples were higher estimated.
There was a tendency that samples with lower (2-copy for
FCGR3A, 1-copy, 2-copy, 3-copy for FCGR3B, and 2-copy, 3-
copy, 4-copy, and 5-copy for FCGR3) copy number were prone
to higher estimation. Samples with higher copy numbers (4-copy
for FCGR3B, 6-copy and 7-copy for FCGR3) were tended to be
lower estimated.
DISCUSSION
In the present study, after the comparison of PRT-REDVR,
TaqMan qPCR, SYBR Green qPCR, and STR, we found that
TaqMan qPCR was the statistically supported method which
could detect the copy number more accurately at FCGR3 region
in the HapMap CHB and JPT population in our institute. qPCR
was widely used and criticized by its veracity and reliability as it
could potentially introduce false positive calls. In our research,
this problem might be involved in our SYBR Green qPCR
assay. SYBR Green qPCR showed the lowest concordant rate
and correlation with results from database in FCGR3B detection.
Therefore, we refined the method of TaqMan qPCR in FCGR3A,
FCGR3B, and FCGR3 copy number determination. And TaqMan
qPCR showed the highest concordant rate with 1000 genome
sequencing data and correlation with the array-CGH results. Our
data showed that TaqMan qPCR assay might be an option for
future high throughput case-control study.
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We used two standard populations from the HapMap project,
45 CHB and 45 JPT individuals. Previous studies by other
groups also defined the copy number of HapMap CHB and
JPT populations. We also compared the previously reported
results with 1000 genome sequencing data and array-CGH
result in paired samples (Hollox et al., 2009). The correlation
between previously reported data and array-CGH results was
0.618 (p < 0.001) and the concordant rate was 85.88% for
FCGR3A, 78.82% for FCGR3B and 70.59% for FCGR3 comparing
with 1000 genome sequencing data. The differences in copy
number detection in one sample by the four methods (Taqman,
SYBR Green, PRT-REDVR, and STR) individually could reflect
either measurement error or real copy number heterogeneity
between repeats. Meanwhile, the integration of multiple methods
could improve the accuracy. The integrated copy number FCGR3
showed 89.4% consistency with the 1000 genome sequencing
data which was higher than using PRT (72.94%), STR (75.29%),
and Taqman (81.18%) alone. The integrated copy number
FCGR3 also showed higher (0.932) correlation with the whole-
genome tiling BAC array data than using PRT (0.667), STR
(0.677), and Taqman (0.726) alone. Comparing with the result of
single method, the integration by several methods would surely
improve the accuracy. Our PRT and STR results were successfully
replicated the previous reported data which also based on these
two methods. However, TaqMan qPCR refined by our laboratory
showed better performance than PRT. Our finding suggested that
before case-control association studies, methodologies should be
confirmed with standard population. That is to detect certain
gene copy number using multiple methods in the standard
population and followed by comparing the results with array-
CGH results or 1000 genome sequencing data for methodology
evaluation. Array-CGH reflects copy numbers based on relative
dosage signal and the 1000 genome sequencing data precisely
presented every copy number for each sample from a certain
locus. Array-CGH had been utilized for detection evaluation by
other groups (Hollox et al., 2009). However, we proposed that
1000 genome sequencing data would be a better option and
array-CGH could be an implement in methodology evaluation.
In this way, any laboratory could find a suitable method
for copy number detection with minimum error rate. And
method refinement would further improve the accuracy of
detection.
Our study aims to find a better way to determine FCGR3
genomic copy number in Asia populations. Nevertheless,
TaqMan qPCR, PRT-REDVR, STR, SYBR Green qPCR were
prone to detect a higher copy number. Therefore, in order to
improve the accuracy in copy number determination in samples
with high copy numbers, a combination of two or more methods
was required. Our refined TaqMan qPCR alone was statistically
supported as an option in FCGR3 copy number determination
for future case-control association studies. Advantages include
small amount of DNA, high-throughput analysis, low running
cost, and feasibility of equipment. However, this method could
potentially introduce false positive results and DNA integrity
should also be warranted. We hoped such endeavor will benefit
future case-control studies with regard to complex CNVs,
particularly for disease associations with genetic variations
of FcγRs.
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